[1]曾晓峰,郑伟,乌守恒,等.13例系统性红斑狼疮患者避孕措施选择的临床分析[J].中国计划生育和妇产科,2018,(6):51-54.
 ZENG Xiao-feng,ZHENG Wei,WU Shou-heng,et al.Contraceptive methods for women with systemic lupus erythematosus:13 cases of clinical analysis[J].Chinese Journal of Family Planning & Gynecotokology,2018,(6):51-54.
点击复制

13例系统性红斑狼疮患者避孕措施选择的临床分析
分享到:

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2018年6期
页码:
51-54
栏目:
论著与临床
出版日期:
2018-06-25

文章信息/Info

Title:
Contraceptive methods for women with systemic lupus erythematosus:13 cases of clinical analysis
作者:
曾晓峰郑伟乌守恒王萍周颖林卫*
四川大学华西第二医院妇产科
Author(s):
ZENG Xiao-fengZHENG WeiWU Shou-hengWANG PingZHOU YingLIN Wei*
Department of Obstetrics and Gynecology,West China Second University Hospital Sichuan University,Chengdu Sichuan 610041,P.R.China
关键词:
避孕系统性红斑狼疮PAC咨询人工流产
Keywords:
contraceptionsystemic lupus erythematosus PAC consultationartificial abortion
分类号:
R 715
摘要:
目的探讨系统性红斑狼疮(systemic lupus erythematosus,SLE)患者流产后避孕措施的选择并随访避孕结局。 方法对13例2014年2月至2017年2月在四川大学华西第二医院行人工流产术并接受了流产后关爱(Post-Abortion Care,PAC)咨询的SLE患者进行回顾性分析,随访其避孕结局。结果13例SLE患者PAC咨询前长效可逆避孕措施(long-acting reversible contraception,LARC)使用率为0 %,其中意外妊娠者11例,2例为计划内妊娠胚胎停育;PAC咨询后有4例患者选择宫内节育系统,2例选择含铜宫内节育器,7例选择男用避孕套,LARC使用率为462 %;13例患者平均随访(226±91)月,均未发生意外妊娠,无避孕不良反应、无SLE病情加重;其中有4例获得满意的计划内妊娠。结论SLE患者的妊娠必须是有计划且高度重视。PAC咨询能明显改善SLE患者避孕观念和促进LARC落实。临床工作者应综合权衡患者个体危险因素及SLE的活动性、抗磷脂抗体状态等,给予最佳的避孕指导。
Abstract:
ObjectiveTo discuss the contraceptive methods for women with systemic lupus erythematosus,to give a clinic reference in future contraceptive consultation for women with systemic lupus erythematosus.Methods13 cases with systemic lupus erythematosus who underwent artificial abortion and PAC consultation in West China Second University Hospital were analyzed retrospectively.ResultsThe utilization rate of LARC is 0 % before PAC consultation. However,4 patients chose IUS, 2 patients chose IUD, 7 cases chose male condoms,the utilization rate of LARC is 46.2 % after PAC consultation.With an average follow-up of 226±917 months, there were no unexpected pregnancy, contraception adverse reaction and SLE disease progression were found in the 13 patients;4 patients achieved satisfactory planned pregnancy. ConclusionThe pregnancy of patients with SLE must be planned. All women of reproductive age with SLE should be strictly in birth control. Clinicians should consider the patient's individual risk factors and SLE activity, aPL state, etc., to give the best contraceptive consultation.

参考文献/References:

[1]Clowse M E B Lupus activity in pregnancy[J]. Rheumatic Diseases Clinics of North America, 2007, 33(2):237. [2]中国系统性红斑狼疮研究协作组专家组.国家风湿病数据中心.中国系统性红斑狼疮患者围产期管理建议 [J].中华医学杂志,2015,95(14):1056-1060. [3]YAZDANY J, TRUPIN L, KAISER R, et al. Contraceptive counseling and use among women with systemic lupus erythematosus:a gap in health care quality[J].Arthritis Care & Research. Mar , 2011, 63(3): 358-365. [4]Andreoli L, Bertsias G K, Agmon-Levin N, et al. EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome[J]. Annals of the Rheumatic Diseases, 2017, 76(3):476-485. [5]金力.合并基础疾病妇女避孕方法的选择——世界卫生组织《避孕方法选用的医学标准》重点解读 [J].国际生殖健康/计划生育杂志,2013,32(2):143-148. [6]CURTIS K M, TEPPER N K, JATLAOUI T C, et al. U [J]. Medical Eligibility Criteria for Contraceptive Use, 2016, 65(3): 1-103. [7]TRUSSELL J. Contraceptive failure in the United States [J]. Contraception, 2004, 70(2): 89-96. [8]Culwell K R, Curtis K M, Del C C M. Safety of contraceptive method use among women with systemic lupus erythematosus: a systematic review [J]. Obstetrics & Gynecology, 2009, 114(1):341-353. [9]SARABI Z S, CHANG E, BOBBA R, et al. Incidence rates of arterial and venous thrombosis after diagnosis of systemic lupus erythematosus [J]. Arthritis and Rheumatism, 2005, 53(4): 609-612. [10]Berenson A. Committee Opinion No. 602: Depot medroxyprogesterone acetate and bone effects. [J]. Obstetrics & Gynecology, 2014, 123(6):1398-1402. [11] 刘淳,刘彦虹.抗磷脂抗体促进血栓形成机制的研究 [J].现代检验医学杂志,2014,29(1):16-19. [12]Choojitarom K, Verasertniyom O, Totemchokchyakarn K, et al. Lupus nephritis and Raynaud's phenomenon are significant risk factors for vascular thrombosis in SLE patients with positive antiphospholipid antibodies[J]. Clinical Rheumatology, 2008, 27(3):345-351. [13] URBANUS R T, SIEGERINK B, ROEST M, et al. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study [J]. Lancet Neurology, 2009, 8(11): 998-1005. [14] PETRI M, KIM M Y, KALUNIAN K C, et al. Combined oral contraceptives in women with systemic lupus erythematosus [J]. New England Journal of Medicine, 2005, 353(24): 2550-2558. [15] DREYER L, FAURSCHOU M, MOGENSEN M, et al. High incidence of potentially Virus-Induced malignancies in systemic lupus erythematosus a long-term followup study in a Danish cohort [J]. Arthritis and Rheumatism, 2011, 63(10): 3032-3037. [16] International Collaboration of Epidemiological Studies of Cervical Cancer, APPLEBY P, BERAL V, et al. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies [J]. Lancet, 2007, 370(9599): 1609-1621.

相似文献/References:

[1]魏艳秋,苏士利,董白桦,等.左炔诺孕酮宫内缓释系统临床使用的安全性研究[J].中国计划生育和妇产科,2011,(03):0.
[2]钟兴明,张迪,桑丽英,等.广州市天河区流动人口生殖健康现状调查[J].中国计划生育和妇产科,2011,(04):0.
 ZHONG Xing-ming,ZHANG Di,SANG Li-ying,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(6):0.
[3]卢希平,陈尧,朱海芳,等.人工流产妇女避孕行为调查及干预[J].中国计划生育和妇产科,2011,(05):0.
 LU Xi-ping,CHEN Yao,ZHU Hai-fang,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(6):0.
[4]鞠方,雷贞武.目前有关避孕药安全性的争议问题[J].中国计划生育和妇产科,2013,(03):0.
 JU Fang,LEI Zhen - wu * ..[J].Chinese Journal of Family Planning & Gynecotokology,2013,(6):0.
[5]柴明涵,董白桦.左炔诺孕酮宫内缓释系统的临床应用[J].中国计划生育和妇产科,2014,(03):0.
[6]苏萍,郭建新,易萍,等.流产后关爱服务的应用现状[J].中国计划生育和妇产科,2015,(09):0.
[7]刘粉年,周迎,王文平,等.1082例人工流产原因分析[J].中国计划生育和妇产科,2015,(11):0.
 LIU Fen-nian,ZHOU Ying,WANG Wen-ping,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2015,(6):0.
[8]毕小霞.人工流产女性避孕现状及其影响因素分析[J].中国计划生育和妇产科,2015,(12):0.
 BI Xiao-xia,[J].Chinese Journal of Family Planning & Gynecotokology,2015,(6):0.
[9]倪飞英*,段洁,赵芳,等.高危人群人工流产后立即高效避孕的临床观察[J].中国计划生育和妇产科,2017,(4):45.
 NI Fei-ying*,DUAN Jie,ZHAO Fang,et al.Clinical observation of high effective contraception immediately after induced abortion in high risk population[J].Chinese Journal of Family Planning & Gynecotokology,2017,(6):45.
[10]廖海霞,蔡春华,朱明辉*.辅助生殖术后妊娠合并盆腔脓肿伴系统性红斑狼疮[J].中国计划生育和妇产科,2019,(10):48.

备注/Memo

备注/Memo:
成都市科技局软科学项目(项目编号:0040215302038);中国人口福利基金会和杰—玛丽斯特普青年长效可逆避孕(青年LARC)专项研究基金(项目编号:GJB-3-20180302-46)
更新日期/Last Update: 2018-06-25